{
  "docId": "019de077-03c2-7682-9c49-749c55840a7d",
  "docSlug": "7d4a71c8904800c2c7c70f8e07dfcf66",
  "documentTitle": "Exscientia | Results Presentation Deck | 22 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 22,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a circular diagram centered on a human silhouette to integrate three key pillars of the drug development strategy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-03c2-7682-9c49-749c55840a7d/17",
  "deckHref": "/decks/019de077-03c2-7682-9c49-749c55840a7d",
  "deckJsonHref": "/decks/019de077-03c2-7682-9c49-749c55840a7d.json",
  "deckAnchorHref": "/decks/019de077-03c2-7682-9c49-749c55840a7d#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.46,
        "x": 0.27,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Circular strategy diagram with three segments: Mechanistic Rationale, Target Population, and Model-informed Drug Development",
      "attrs": null,
      "subkind": "other",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8965767d-6ffa-4062-a22c-f7dfcda8fdd0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.08,
        "y": 0.3
      },
      "kind": "list",
      "text": "LSD1 inhibition promotes cell differentiation in AML & SCLC; '539 has demonstrated efficacy in vivo and ex vivo studies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20efea7e-0f78-4884-b65c-16ab980f59f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.7,
        "y": 0.43
      },
      "kind": "list",
      "text": "Expect to commence first trial in either AML and/or SCLC patients in 2024; Patient selection work ongoing with precision medicine platform",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2456398f-69ba-4e0d-8f97-ab38c9d25224",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.11,
        "y": 0.68
      },
      "kind": "list",
      "text": "Applying biological/statistical models from clinical and preclinical data to assess benefits/risks and inform decisions",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee9a917d-acd6-4498-86c4-f6c4a4b29420",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "First-in-patient trial expected to commence in 2024",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80c43dc2-da87-4747-905a-95117503cbdb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "‘539: LSD1 inhibitor moving into patient trials",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98ec36b0-5652-4e54-96ba-3cacb6f37a2a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 17,
      "from": 13,
      "beatId": "ac22c057-1c2d-4a7e-9615-3a68519957b2",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The deck showcases pipeline updates and proposed solutions",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 17,
      "from": 13,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "59bbe9a5-4dee-402a-a171-3cbe1ef4dc26",
      "evidence": "The deck presents a logic chain with pipeline updates and proposed solutions",
      "position": 1,
      "objective": "How does Exscientia's pipeline support its growth strategy?",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.6,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}